N-methyl-D-aspartate and σ-ligands change the production of interleukins 8 and 10 in lymphocytes through modulation of the NMDA glutamate receptor

NeuroImmunoModulation

Volumn 16, Issue 3, 2009, Pages 201-207

  Kvaratskhelia, Eka ^a   Maisuradze, Ekaterine ^a   Dabrundashvili, Nino G ^a   Natsvlishvili, Nino ^b,c   Zhuravliova, Elene ^b,c   Mikeladze, David G ^a,b,c  

^a Institute of Medical Biotechnology   (Georgia)

^b Tbilisi St Andrew the First Called Georgian University of Georgian Patriarchate   (Georgia)

^c ILIA STATE UNIVERSITY   (Georgia)

Author keywords

Ligands; c Fos; N methyl D aspartate glutamate receptor; NF B; T lymphocytes

Indexed keywords

DEXTRORPHAN; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 8; LIGAND; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PENTAZOCINE; SIGMA 1 OPIATE RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IL10 GENE; IL8 GENE; INTERNALIZATION; NORMAL HUMAN; ONCOGENE C FOS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; T LYMPHOCYTE; WESTERN BLOTTING;

DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; INTERLEUKINS; JURKAT CELLS; LYMPHOCYTES; NEUROIMMUNOMODULATION; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; RNA, MESSENGER; UP-REGULATION;

EID: 60749137415     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000204234     Document Type: Article

References (35)

1. Danbolt NC: Glutamate uptake. Prog Neurobiol 2001;65:1-105.
2. Lombardi G, Dianzani C, Miglio G, Canonico PL, Fantozzi R: Characterization of ionotropic glutamate receptors in human lymphocytes. Br J Pharmacol 2001;133:936-944.
3. Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M: Human T cells express a functional ionotropic glutamate receptor, GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol 2003;170:4362-4372.
4. Boldyrev AA, Kazey VI, Leinsoo TA, Mashkina AP, Tyulina OV, Johnson P, et al: Rodent lymphocytes express functionally active glutamate receptors. Biochem Biophys Res Commun 2004;324:133-139.
5. Miglio G, Varsaldi F, Lombardi G: Human T lymphocytes express N-methyl-Daspartate receptors functionally active in controlling T cell activation. Biochem Biophys Res Commun 2005;338:1875-1883.
6. Chiocchetti A, Miglio G, Mesturini R, Varsaldi F, Mocellin M, Orilieri E, et al: Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes. Br J Pharmacol 2006;148:760-768.
7. Poulopoulou C, Markakis I, Davaki P, Nikolaou C, Poulopoulos A, Raptis E, et al: Modulation of voltage-gated potassium channels in human T lymphocytes by extracellular glutamate. Mol Pharmacol 2005;67:856-867.
8. Boldyrev AA, Carpenter DO, Johnson P: Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J Neurochem 2005;95:913-918.
9. Graham TE, Sgro V, Friars D, Gibala MJ: Glutamate ingestion: the plasma and free amino acid pools of resting humans. Am J Physiol 2000;278:83-89.
10. Kostanyan IA, Merkulova MI, Navolotskaya EV, Nurieva RI: Study of interaction between L-glutamate and human blood lymphocytes. Immunol Lett 1997;58:177-180.
11. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG: Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 2000;3:661-669.
12. Bowen WD: Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv 2000;74:211-218.
13. Su TP, Hayashi T: Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 2003;10:2073-2080.
14. 3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Mol Pharmacol 1992;41:134-146.
15. Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM: Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol Pharmacol 1996;50:1541-1550.
16. Natchkebia K, Natsvlishvili N, Mikeladze D: Effect of phencyclidine, MK-801 and dextrorphan on the viability of neuronal/glial cells and expression of NMDA-receptor subunits, PSD-95, nNOS and Ras-GRF1. J Biol Phys Chem 2003;3:18-22.
17. Zhuravliova E, Barbakadze T, Natsvlishvili N, Mikeladze DG: Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity. Neurochem Int 2007;50:976-982.
18. Bourrie B, Bribes E, De Nys N, Esclangon M, Garcia L, et al: SSR125329A, a high affinity σ receptor ligand with potent anti-inflammatory properties. Eur J Pharmacol 2002;456:123-131.
19. kip1 accumulation. J Pharmacol Exper Ther 2004;311:1105-1114.
20. Baggiolini M, Loetscher P, Moser B: Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995;17:103-108.
21. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M: Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002;72:847-855.
22. Grütz G: New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 2005;77:3-15.
23. Asadullah K, Sterry W, Volk HD: Interleukin-10 therapy - review of a new approach. Pharmacol Rev 2003;55:241-269.
24. Meisel C, Vogt K, Platzer C, Randow F, Liebenthal C, Volk HD: Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression. Eur J Immunol 1996;26:1580-1586.
25. Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann G: Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 2001;50:76-82.
26. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
27. Ganapathy ME, Prasad PD, Huang W, Seth P, Leibach FH, Ganapathy V: Molecular and ligand-binding characterization of the σ-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 1999;289:251-260.
28. Williams MS, Noguchi S, Henkart PA, Osawa Y: Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol 1998;161:6526-6531.
29. Pacheco R, Oliva H, Martinez-Navio JM, Climent N, Ciruela F, Gatell JM, et al: Glutamate released by dendritic cells as a novel modulator of T cell activation. J Immunol 2006;177:6695-6704.
30. Dávalos A, José Castillo J, Serena J, Noya M: Duration of glutamate release after acute ischemic stroke. Stroke 1997;28:708-710.
31. del Zoppo GJ, Becker KJ, Hallenbeck JM: Inflammation after stroke: is it harmful? Arch Neurol 2001;58:669-672.
32. Beckman JS, Beckman TW, Chen J, Marshall PM, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and peroxynitrite. Proc Natl Acad Sci USA 1990;87:1620-1624.
33. Zouki C, József L, Ouellet S, Paquette Y, Filep JG: Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J Leukoc Biol 2001;69:815-824.
34. Ray N, Kuwahara M, Takada Y, Maruyama K, Kawaguchi T, Tsubone H, et al: c-Fos suppresses systemic inflammatory response to endotoxin. Int Immunol 2006;18:671-677.
35. Serhan CN, Savill J: Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6:1191-1197.